Concepedia

Xin Liang

XL

Statistics

Publications

83

Citations

3.9K

H-Index

37

Active since

2008

Affiliations

East China University of Science and Technology(Current)

Shanghai University of Traditional Chinese Medicine

Capital Medical University

Longhua Hospital Shanghai University of Traditional Chinese Medicine

Emory University

Xin Liang is an author at East China University of Science and Technology specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2008–2024

83

Publications

83

A New Class of Naphthalimide-Based Antitumor Agents That Inhibit Topoisomerase II and Induce Lysosomal Membrane Permeabilization and Apoptosis

Zhuo Chen, Xin Liang, Huanying Zhang et al. · Journal of Medicinal Chemistry · 2010 · 169 citations

, , +15

Hypoxia Induces Drug Resistance in Colorectal Cancer through the HIF-1α/miR-338-5p/IL-6 Feedback Loop

Ke Xu, Yueping Zhan, Zeting Yuan et al. · Molecular Therapy · 2019 · 165 citations · Full text

, , +17

MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling

Ke Xu, Guo Chen, Xiaobo Li et al. · Scientific Reports · 2017 · 160 citations · Full text

, , +16

MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2

Lin Zhou, Xin Liang, Lingling Zhang et al. · Oncotarget · 2016 · 135 citations · Full text

, , +13

miR-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2

Qingguo Li, Xin Liang, Yuwei Wang et al. · Scientific Reports · 2016 · 122 citations · Full text

, , +17

1–5 of 83